KORU Medical Systems, Inc. (KRMD)
$3.26+$0.06 (+1.87%) Today
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 12,500 | $49K |
| Grant or award | 8 | 594,000 | |
| Option exercise | 1 | 75,000 | |
| Tax withholding / forfeiture | 1 | 25,483 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
54 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Adam R. Kalbermatten - Officer | Option exercise | Common Stock | 75,000 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Tax withholding / forfeiture | Common Stock | 25,483 | $4.26 | $109K | |
| Adam R. Kalbermatten - Officer | Grant or award | Performance Stock Unit | 284,091 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Grant or award | Performance Stock Unit | 286,697 | $0.00 | - | |
| Edward Wholihan - Director | Grant or award | Common Stock | 3,571 | $4.20 | $15K | |
| Shahriar Matin - Director | Grant or award | Common Stock | 3,571 | $4.20 | $15K | |
| Donna French - Director | Grant or award | Common Stock | 3,571 | $4.20 | $15K | |
 R. John Fletcher - Director | Grant or award | Common Stock | 5,357 | $4.20 | $22K | |
| Robert Cascella - Director | Grant or award | Common Stock | 3,571 | $4.20 | $15K | |
| Joseph M. Manko Jr. - Director | Grant or award | Common Stock | 3,571 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Open-market purchase | Common Stock | 5,000 | $3.96 | $20K | |
| Adam R. Kalbermatten - Officer | Open-market purchase | Common Stick | 7,500 | $3.93 | $29K | |
| Eric Schiller - Officer | Open-market purchase | Common Stock | 5,000 | $3.91 | $20K | |
| Linda M. Tharby - Officer | Open-market purchase | Common Stock | 1,191 | $1,191.00 | $1.42M | |
| Linda M. Tharby - Officer | Option exercise | Common Stock | 13,977 | $0.00 | - | |
| Linda M. Tharby - Officer | Tax withholding / forfeiture | Common Stock | 7,326 | $3.94 | $29K | |
| Christopher Pazdan - Officer | Open-market purchase | Common Stock | 5,000 | $3.88 | $19K | |
| Thomas Edward Adams - Officer | Option exercise | Common Stock | 8,193 | $0.00 | - | |
| Thomas Edward Adams - Officer | Tax withholding / forfeiture | Common Stock | 2,900 | $3.94 | $11K | |
| Joseph M. Manko Jr. - Director | Grant or award | Common Stock | 3,472 | $0.00 | - | |
| Shahriar Matin - Director | Grant or award | Common Stock | 3,472 | $4.32 | $15K | |
| Donna French - Director | Grant or award | Common Stock | 3,472 | $4.32 | $15K | |
| Edward Wholihan - Director | Grant or award | Common Stock | 3,472 | $4.32 | $15K | |
| Robert Cascella - Director | Grant or award | Common Stock | 3,472 | $4.32 | $15K | |
| R. John Fletcher - Director | Grant or award | Common Stock | 5,208 | $4.32 | $22K | |
| Joseph M. Manko Jr. - Director | Grant or award | Common Stock | 3,472 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Grant or award | Restricted Stock Unit | 45,098 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Grant or award | Performance Stock Unit | 45,098 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Grant or award | Option to buy Common Stock | 67,779 | $0.00 | - | |
| Christopher Pazdan - Officer | Option exercise | Common Stock | 5,064 | $0.00 | - | |
| Christopher Pazdan - Officer | Tax withholding / forfeiture | Common Stock | 1,628 | $4.28 | $7K | |
| Christopher Pazdan - Officer | Grant or award | Restricted Stock Unit | 31,226 | $0.00 | - | |
| Christopher Pazdan - Officer | Grant or award | Performance Stock Unit | 31,226 | $0.00 | - | |
| Christopher Pazdan - Officer | Grant or award | Option to buy Common Stock | 46,929 | $0.00 | - | |
| Thomas Edward Adams - Officer | Option exercise | Common Stock | 5,404 | $0.00 | - | |
| Thomas Edward Adams - Officer | Tax withholding / forfeiture | Common Stock | 2,123 | $4.28 | $9K | |
| Thomas Edward Adams - Officer | Grant or award | Restricted Stock Unit | 38,918 | $0.00 | - | |
| Thomas Edward Adams - Officer | Grant or award | Performance Stock Unit | 38,918 | $0.00 | - | |
| Thomas Edward Adams - Officer | Grant or award | Option to buy Common Stock | 58,490 | $0.00 | - | |
| Linda M. Tharby - Officer | Option exercise | Common Stock | 15,968 | $0.00 | - | |
| Linda M. Tharby - Officer | Tax withholding / forfeiture | Common Stock | 5,756 | $4.28 | $25K | |
| Joseph M. Manko Jr. - Director | Other | Common Stock | 770,418 | $0.00 | - | |
| Joseph M. Manko Jr. - Director | Other | Common Stock | 750,000 | $0.00 | - | |
| Joseph M. Manko Jr. - Director | Other | Common Stock | 750,000 | $0.00 | - | |
| Joseph M. Manko Jr. - Director | Other | Common Stock | 282,347 | $0.00 | - | |
| Eric Schiller - Officer | Grant or award | Common Stock | 76,426 | $0.00 | - | |
| Eric Schiller - Officer | Grant or award | Option to buy Common Stock | 232,297 | $0.00 | - | |
| Joseph M. Manko Jr. - Director | Other | Common Stock | 41,000 | $0.00 | - | |
| Linda M. Tharby - Officer | Grant or award | Common Stock | 29,463 | $4.08 | $120K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| KALBERMATTEN ADAM R | Officer | 25,483 | $109K | View on EDGAR | |
| - | - | - | - | View on EDGAR |
KORU Medical Systems, Inc. (KRMD) had 10 insider filings in the last 90 days, with the most recent on 2026-08-06. The full record for KRMD runs to 54 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of KRMD were filed in the last 90 days, totaling $49K.
No insider sales of KRMD were filed in the last 90 days.
This page tracks KRMD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add KRMD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
